PortViewPortView
SomaLogic logo

SomaLogic (SLGC) Stock Analysis

NASDAQHealthcareMedical - Healthcare Information Services

$2.10-4.55%
1-year price historyRange $1.76 – $3.60
52-week range$2.10
$1.73$3.79

What SomaLogic does

SomaLogic, Inc. is a U.S.-based enterprise specializing in the identification of protein biomarkers and the development of clinical diagnostic solutions. A core aspect of its technology involves the creation of slow off-rate modified aptamers (SOMAmers) – unique nucleic acid-based reagents meticulously designed to specifically bind with their target proteins. The company also provides its proprietary SomaScan services, which enable the simultaneous detection and precise quantification of numerous proteins within intricate biological samples. This integrated SOMAmer and SomaScan platform empowers researchers to analyze diverse biological specimens, uncovering protein biomarker signatures invaluable for pharmaceutical discovery and development initiatives. Furthermore, the biomarker insights gleaned from SomaScan are instrumental in developing diagnostic applications across a range of conditions, such as cardiovascular and metabolic diseases, nonalcoholic steatohepatitis (NASH), and for general wellness monitoring. SomaLogic additionally furnishes SomaSignal tests, available for both research use only (RUO) and as laboratory-developed tests (LDTs). The firm caters to both research and clinical clients, primarily comprising pharmaceutical and biotechnology companies, as well as academic research institutions. These offerings support various stages of drug development, facilitate the analysis of clinical trials, and contribute to novel insights into human biology through the investigation of protein-protein and protein-gene interactions. Established in 1999, SomaLogic maintains its corporate headquarters in Boulder, Colorado.

Key metrics

Market cap
$396.23M
P/E (TTM)
-3.04
EPS (TTM)
$-0.69
Beta
1.64
Dividend yield
0.00%
Revenue / share
$0.53
50-day avg
$2.43
200-day avg
$2.45
52-week high
$3.79
52-week low
$1.73
CEO
Stephen A. Williams BS, MB,

ETFs linked to SLGC

Broad-market and Healthcare sector ETFs an investor holding SomaLogic is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SLGC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SLGC in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for SomaLogic?
SomaLogic trades under the ticker SLGC on NASDAQ.
Which exchange is SLGC listed on?
SLGC is listed on NASDAQ.
What sector does SomaLogic operate in?
SomaLogic is classified in the Healthcare sector (Medical - Healthcare Information Services industry).
How can PortView help analyze SLGC in a portfolio?
PortView shows SLGC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.